Literature DB >> 9858896

Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer.

J Dimberg1, A Samuelsson, A Hugander, P Söderkvist.   

Abstract

The development of intestinal tumours in the Min mouse is influenced by Moml locus, where the group II phospholipase A2 (PLA2-II) gene has been suggested as the candidate gene. Since no causative genetic alterations have been identified in PLA2-II in human colorectal tumours, we tested whether PLA2-II or the cytosolic isoform cPLA2, are dysregulated in human colorectal carcinogenesis. By means of RT-PCR, the expression of these genes and cyclooxygenase-2 (COX-2), which is upregulated in colorectal tumours, were examined. No changes in gene expression of PLA2-II were found in 44 tumours compared to normal mucosa. cPLA2 and COX-2 were upregulated; however, no correlation in expression was found between these genes. Thus, the supply of arachidonic acid provided by PLA2-II/cPLA2 seems not to be the rate limiting step in PGE2 (a prostaglandin/mitogen) formation via COX-2 and PLA2-II plays a minor or no role in human colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858896

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon.

Authors:  Zora Djuric
Journal:  Nutr Rev       Date:  2011-12       Impact factor: 7.110

2.  Effects of the inhibition of cytosolic phospholipase A(2)α in non-small cell lung cancer cells.

Authors:  Shenbagamoorthy Sundarraj; Soundarapandian Kannan; Ramar Thangam; Palani Gunasekaran
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-25       Impact factor: 4.553

3.  Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells.

Authors:  D A Dixon; N D Tolley; P H King; L B Nabors; T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

4.  In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection.

Authors:  G Nardone; E L Holicky; J R Uhl; L Sabatino; S Staibano; A Rocco; V Colantuoni; B A Manzo; M Romano; G Budillon; F R Cockerill; L J Miller
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Differential expression of cyclooxygenase 2 in human colorectal cancer.

Authors:  J Dimberg; A Samuelsson; A Hugander; P Söderkvist
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

6.  Cytosolic phospholipase A2-p11 interaction controls arachidonic acid release as a function of epithelial cell confluence.

Authors:  Anne Bailleux; Dominique Wendum; François Audubert; Anne-Marie Jouniaux; Kamen Koumanov; Germain Trugnan; Joëlle Masliah
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 7.  Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.

Authors:  Denis E Corpet; Fabrice Pierre
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

8.  Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.

Authors:  Sung Chul Lim; Hoon Cho; Tae Bum Lee; Cheol Hee Choi; Young Don Min; Sung Soo Kim; Kyung Jong Kim
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

9.  Prognostic significance of cytosolic phospholipase A2 expression in patients with colorectal cancer.

Authors:  Young Sun Yoo; Sung Chul Lim; Kyung Jong Kim
Journal:  J Korean Surg Soc       Date:  2011-06-09

10.  CXCR4 in Cancer and Its Regulation by PPARgamma.

Authors:  Cynthia Lee Richard; Jonathan Blay
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.